1. Home
  2. EIG vs BBNX Comparison

EIG vs BBNX Comparison

Compare EIG & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EIG

Employers Holdings Inc

HOLD

Current Price

$51.80

Market Cap

793.6M

Sector

Finance

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.49

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
BBNX
Founded
2000
2015
Country
United States
United States
Employees
N/A
423
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
793.6M
493.1M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EIG
BBNX
Price
$51.80
$16.49
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$23.80
AVG Volume (30 Days)
294.6K
1.1M
Earning Date
04-29-2026
04-21-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
$34.90
Revenue Next Year
$1.26
$34.63
P/E Ratio
$99.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$8.80
52 Week High
$51.93
$32.71

Technical Indicators

Market Signals
Indicator
EIG
BBNX
Relative Strength Index (RSI) 79.39 67.27
Support Level $41.02 $16.02
Resistance Level N/A $32.52
Average True Range (ATR) 1.10 1.07
MACD 0.39 0.16
Stochastic Oscillator 100.00 89.90

Price Performance

Historical Comparison
EIG
BBNX

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: